Unknown NA INTERVENTIONAL 2-arm NCT03863535

PRP vs PRP+IVC for Severe nPDR

Panretinal Photocoagulation (PRP) vs PRP Combined With Intravitreous Conbercept (IVC) for Severe Nonproliferative Diabetic Retinopathy (nPDR): A Randomized Clinical Trial

Sponsor: Ruijin Hospital

Conditions Diabete Mellitus Diabetic Retinopathy Severe Nonproliferative Diabetic Retinopathy

Interventions Conbercept Panretinal coagulation

Updated 5 times since 2019 Last updated: Mar 3, 2019 Started: Jan 18, 2019 Primary completion: Jan 1, 2021 Completion: Sep 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Diabete Mellitus and Diabetic Retinopathy and is currently ongoing. Ruijin Hospital leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Nov 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Nov 2021 [monthly]

Recruiting NA
Apr 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Jan 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ruijin Hospital
Shanghai Municipal Science and Technology Commission

Data source: Ruijin Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China